Delphi Consensus Outlines Anti-TNF Introduction, Monitoring Guidelines for Patients with IBD

Experts recommended the early use of anti-TNF therapy for patients with ulcerative colitis and Crohn disease, offering further input regarding the introduction, optimization, and maintenance of the treatment for patients with IBD.

Related Keywords

Milan ,Lombardia ,Italy ,Fatebenefratelli Sacco ,University Of Milan ,Drug Administration ,Enthera Pharmaceuticals Sandro Ardizzone ,Enthera Pharmaceuticals ,Sandro Ardizzone ,Dig Liver ,Inflammatory Bowel Disease ,Accessed October ,Tumor Necrosis Factor ,Anti Tnf ,Anti Tnf Therapy ,Anti Tumor Necrosis Factor Therapy ,Delphi ,Consensus ,Introduction ,Optimization ,Maintenance ,Ibd ,Ulcerative Colitis ,Uc ,Crohn Disease ,Cd ,Crohn X27s Disease ,